Nexosome Oncology Holdings, Inc. — Form D
Nexosome Oncology Holdings, Inc. of LEXINGTON, KY, a company, filed a Form D exempt-offering notice with the SEC on 2021-11-22. The offering totals $4.0M, of which $3.7M was reported sold. Industry: Other Health Care.
Offering
- Filed: 2021-11-22
- Form: D
- Accession: 0001894897-21-000001
- Industry: Other Health Care
- Exemptions: 06b
- Total offering: $4.0M
- Amount sold: $3.7M
- Remaining: $348K
- Investors: 48
- Date of first sale: 2021-11-05
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-422096
Issuer
- Name: Nexosome Oncology Holdings, Inc.
- CIK: 0001894897
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2021
- Address: 8700 CORPORATE DRIVE, LEXINGTON, KY, 40503
- Phone: (301) 502-3655
Officers, directors & promoters (6)
| Name | Role | Location |
|---|
| BRIAN BROHMAN | Director | LOUISVILLE, KY |
| Matthew Dicken | Director | Memphis, TN |
| Alan Ezrin | Director | Louisville, KY |
| Todd Hembrough | Director | Lexington, KY |
| Robert Saunders | Director | Chicago, IL |
| Todd Hembrough | Executive Officer | Lexington, KY |
More